Medicines360: Clinical Trials

1 completed, 1 recruiting, 1 terminated. 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	2	Completed 1, Terminated 1

Follow Medicines360: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical Study None (this is an observational study with no intervention) - GDM, Preterm Preeclampsia		Recruiting	Medicines360	5500	2026-09-08	2026-09-30
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding Levonorgestrel 52 mg intrauterine system - Menorrhagia	Phase 3	Completed	Medicines360	105	2019-01-17	2024-05-14
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception LNG20, Mirena - Contraception	Phase 3	Terminated	Medicines360	1910	2009-11-01	2024-08-14

Conditions studied

Fetal Growth Retardation (1)  ·  Menorrhagia (1)  ·  Pre-Eclampsia (1)  ·  Pregnancy Complications (1)

Interventions

Levonorgestrel (2)

Countries

United States (3)

Top investigators

Andrea Olariu, MD, PhD (2)

Results publications

PMID 25934164, PMID 27125892, PMID 29038072, PMID 29560743, PMID 30531565, PMID 31866516, PMID 37023451, PMID 37023455, PMID 38969201